Objective To investigate if the widely publicized warnings in 2003 from the US Food and
Drug Administration about a possible increased risk of suicidality with antidepressant use in …

Drug Administration (FDA) released five safety warnings related to antidepressant use and
the increased risk of suicidality for children. Although researchers have documented a …

Background: Regulatory bodies worldwide, including Health Canada, have issued warnings
about prescribing antidepressants to children and adolescents. We sought to determine …

Prescribing of antidepressants has increased greatly in England and elsewhere in recent
years. 1–3 This increase has coincided with a fall in rates of suicide, leading some …

Objective To assess trends in the use of antidepressants among young suicides after the
warning that these drugs might increase the risk of suicide. Method Individual data of all 845 …

Objective To assess the associations between different antidepressant treatments and the
rates of suicide and attempted suicide or self harm in people with depression. Design Cohort …

Two accompanying observational studies by Biddle and colleagues and Wheeler and
colleagues add to the recent literature regarding changes in antidepressant use and …

Objective To examine the risk of suicidal behaviour within clinical trials of antidepressants in
adults. Design Meta-analysis of 372 double blind randomised placebo controlled trials …

The United States Food and Drug Administration issued a Black Box warning in October
2004 after placebo-controlled trials of antidepressant medications found an increased risk of …

Objective: To estimate the rate and means of suicide among people taking 10 commonly
prescribed antidepressant drugs: dothiepin, amitriptyline, clomipramine, imipramine …